In our study we measured the serum level of both the lipoproteins involved in atherosclerosis and of adiponectin, because they can act coadjuvantically in the development of atherosclerosis (when lipid fractions such as LDL-cholesterol and triglycerides increase in the blood and the serum level of adiponectin decreases). Here, ADIPOQ is linked to atherosclerosis.